Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Zapoteca portoricensis extract may help protect against prostate issues and support liver and kidney health in rats.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Artocarpus heterophyllus seed extract may help treat prostate inflammation without side effects.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Higher cholesterol levels increase aggressive prostate cancer risk.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Finasteride reduces bleeding during prostate surgery.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

New steroids were effective in blocking male hormone receptors in hamster prostates.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Early balding at 40 increases prostate cancer risk.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

α-spinasterol from Melandrium firmum can help reduce prostate enlargement.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.